Hepatology

Top Story

One in four patients with HCV denied initial request for treatment

August 28, 2015

A new study published in PLoS ONE showed that one in four patients with hepatitis C virus infection who apply for treatment of the infection is initially denied.

“Delay in access may further challenge our ability to cure hepatitis C in this country,” Joseph K. Lim, MD, associate professor of medicine and director of the Yale Viral Hepatitis Program at Yale University, said in a press release. “Some patients are told they must wait until they have advanced liver disease before they can undergo potentially curative treatment. We hope these data may help inform national policy discussions on promoting more rational, patient-centered approaches to HCV treatment access.”

Presbyterian/St. Luke's Medical Center launches liver program

August 28, 2015
Presbyterian/St Luke’s Medical Center in Denver, Colo., announced they have expanded their transplant services by adding a liver transplant and liver disease…
In the Journals

Joint model better predicts survival in patients with alcoholic hepatitis

August 28, 2015
Researchers combined results from static and dynamic scoring systems to create a joint-effect model that accurately predicted survival of patients with alcoholic…
In the Journals

Merrem plus Cubicin effective against nosocomial spontaneous bacterial peritonitis

August 27, 2015
Researchers from the University of Padova in Italy found that an antibiotic combination regimen of Merrem and Cubicin was more effective in treating nosocomial…
In the Journals

Cytokines influence impaired cognitive function in children with HCV

August 27, 2015
Researchers in Egypt found a significant correlation between various endogenous cytokines and cognitive impairment among a cohort of Egyptian children with hepatitis C…
More News Headlines »
CME
HBV

Critical Issues in HBV
HBV Management in Complex Populations: Volume 1, Number 2

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »
Meeting News Coverage Video

VIDEO: NAFLD patients need a healthy lifestyle

May 13, 2015
VIENNA — In a video perspective from the 2015 International Liver Congress, Howard Monsour Jr., MD, chief of…
More »
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
morganatic-roan